Laura C Kennedy1, Ingrid A Binswanger1,2, Shane R Mueller1,2,3, Cari Levy4,5, Daniel D Matlock6,7, Susan L Calcaterra1,8, Stephen Koester3,9, Joseph W Frank1,5. 1. Divisions of General Internal Medicine. 2. Institute for Health Research, Kaiser Permanente Colorado, Denver, Colorado. 3. Departments of Health and Behavioral Sciences. 4. Health Care Policy and Research. 5. VA Eastern Colorado Health Care System, Denver, Colorado. 6. Geriatrics, University of Colorado School of Medicine, Aurora, Colorado. 7. Adult and Child Center for Outcomes Research and Delivery Science (ACCORDS), University of Colorado, Aurora, Colorado. 8. Denver Health Medical Center, Denver, Colorado, USA. 9. Anthropology, University of Colorado Denver, Denver, Colorado.
Abstract
Objective: Given the risks of long-term opioid therapy, patients may benefit from tapering these medications. There is little evidence to guide providers' approach to this process. We explored primary care providers' experiences discussing and implementing opioid tapering with patients on long-term opioid therapy. Design: Qualitative study using six semistructured, in-person focus groups. Subject: Primary care providers (N = 40). Setting: Six academically affiliated primary care clinics in university, urban safety net, and Veterans Health Administration medical centers in Colorado. Methods: Focus groups were audio-recorded, transcribed, and analyzed using a mixed inductive-deductive approach in ATLAS.ti. Emergent themes were identified through an iterative, multidisciplinary team-based process. Results: We identified 1) strategies for identifying candidates for opioid tapering, 2) barriers to opioid tapering, and 3) facilitators of opioid tapering. Strategies for identifying candidates for opioid tapering included evidence of high-risk behavior, serious adverse events, opioid-related side effects, and patient preference. Barriers included the providers' emotional burden, inadequate resources, and a lack of trust between patient and provider. Facilitators of opioid tapering included empathizing with the patient's experience, preparing patients for opioid tapering, individualizing implementation of opioid tapering, and supportive guidelines and policies. Conclusions: While discussing and implementing opioid tapering present significant challenges, primary care providers described key facilitators. These findings suggest a need to develop and test the effectiveness of resources to support patient-centered opioid tapering and locally developed policies to support and standardize providers' approaches to opioid prescribing.
Objective: Given the risks of long-term opioid therapy, patients may benefit from tapering these medications. There is little evidence to guide providers' approach to this process. We explored primary care providers' experiences discussing and implementing opioid tapering with patients on long-term opioid therapy. Design: Qualitative study using six semistructured, in-person focus groups. Subject: Primary care providers (N = 40). Setting: Six academically affiliated primary care clinics in university, urban safety net, and Veterans Health Administration medical centers in Colorado. Methods: Focus groups were audio-recorded, transcribed, and analyzed using a mixed inductive-deductive approach in ATLAS.ti. Emergent themes were identified through an iterative, multidisciplinary team-based process. Results: We identified 1) strategies for identifying candidates for opioid tapering, 2) barriers to opioid tapering, and 3) facilitators of opioid tapering. Strategies for identifying candidates for opioid tapering included evidence of high-risk behavior, serious adverse events, opioid-related side effects, and patient preference. Barriers included the providers' emotional burden, inadequate resources, and a lack of trust between patient and provider. Facilitators of opioid tapering included empathizing with the patient's experience, preparing patients for opioid tapering, individualizing implementation of opioid tapering, and supportive guidelines and policies. Conclusions: While discussing and implementing opioid tapering present significant challenges, primary care providers described key facilitators. These findings suggest a need to develop and test the effectiveness of resources to support patient-centered opioid tapering and locally developed policies to support and standardize providers' approaches to opioid prescribing.
Authors: Amy S B Bohnert; Marcia Valenstein; Matthew J Bair; Dara Ganoczy; John F McCarthy; Mark A Ilgen; Frederic C Blow Journal: JAMA Date: 2011-04-06 Impact factor: 56.272
Authors: Tara Gomes; Donald A Redelmeier; David N Juurlink; Irfan A Dhalla; Ximena Camacho; Muhammad M Mamdani Journal: JAMA Intern Med Date: 2013-02-11 Impact factor: 21.873
Authors: Denise Boudreau; Michael Von Korff; Carolyn M Rutter; Kathleen Saunders; G Thomas Ray; Mark D Sullivan; Cynthia I Campbell; Joseph O Merrill; Michael J Silverberg; Caleb Banta-Green; Constance Weisner Journal: Pharmacoepidemiol Drug Saf Date: 2009-12 Impact factor: 2.890
Authors: Marianne S Matthias; Erin E Krebs; Linda A Collins; Alicia A Bergman; Jessica Coffing; Matthew J Bair Journal: Patient Educ Couns Date: 2013-08-02
Authors: Hector R Perez; Michele Buonora; Chinazo O Cunningham; Moonseong Heo; Joanna L Starrels Journal: J Gen Intern Med Date: 2019-08-19 Impact factor: 5.128
Authors: Lucas M Donovan; Carol A Malte; Laura J Spece; Matthew F Griffith; Laura C Feemster; Steven B Zeliadt; David H Au; Eric J Hawkins Journal: Ann Am Thorac Soc Date: 2019-09
Authors: Stephen G Henry; Debora A Paterniti; Bo Feng; Ana-Maria Iosif; Richard L Kravitz; Gary Weinberg; Penney Cowan; Susan Verba Journal: J Pain Date: 2018-09-20 Impact factor: 5.820
Authors: Bobbi Jo H Yarborough; Scott P Stumbo; Ashley Stoneburner; Ning Smith; Steven K Dobscha; Richard A Deyo; Benjamin J Morasco Journal: Pain Med Date: 2019-06-01 Impact factor: 3.750
Authors: Allyn Benintendi; Sarah Kosakowski; Pooja Lagisetty; Marc Larochelle; Amy S B Bohnert; Angela R Bazzi Journal: Drug Alcohol Depend Date: 2021-03-18 Impact factor: 4.492
Authors: Jennifer L Kuntz; John F Dickerson; Jennifer L Schneider; Alison J Firemark; Dea Papajorgji-Taylor; Matthew Slaughter; Katherine R Reese; Lou Ann Thorsness; Mark D Sullivan; Lynn L Debar; David H Smith Journal: J Am Pharm Assoc (2003) Date: 2021-01-21
Authors: Alison J Firemark; Jennifer L Schneider; Jennifer L Kuntz; Dea Papajorgji-Taylor; John F Dickerson; Lou Ann Thorsness; Katherine R Reese; Mark D Sullivan; Lynn L Debar; David H Smith Journal: Pain Med Date: 2021-05-21 Impact factor: 3.750
Authors: Joseph W Frank; Evan Carey; Charlotte Nolan; Anne Hale; Sean Nugent; Erin E Krebs Journal: J Gen Intern Med Date: 2020-11-03 Impact factor: 5.128